Tesamorelin — 10mg

Both are GHRH analogs, but tesamorelin is a full 44-amino acid GHRH analog with a trans-3-hexenoic acid modification for DPP-4 resistance, while sermorelin is only the first 29 amino acids. Tesamorelin is FDA-approved (Egrifta) with specific clinical data on visceral fat reduction via CT imaging. Sermorelin has broader anti-aging clinic use. Tesamorelin is considered more potent for visceral fat specifically.

Yes — tesamorelin (GHRH pathway) and ipamorelin (ghrelin/GHS pathway) stimulate GH release through two independent receptor systems. This dual-pathway approach is studied for potentially amplified GH output compared to either compound alone. This is one of the most popular GH peptide stacks for targeted visceral fat reduction.

Published clinical protocols use 2mg SC daily continuously. The research community typically runs 3-6 month cycles with 1-2 month breaks. CT imaging studies showed visceral fat reduction within 8-12 weeks, with continued improvement through 6 months. Most anti-aging practitioners recommend monitoring IGF-1 levels periodically during use.

Both are GHRH analogs. Tesamorelin is more potent, has FDA approval, and has stronger clinical data. Sermorelin has a longer track record and lower cost.

Yes. Tesamorelin is FDA-approved as Egrifta® for reduction of excess abdominal fat in HIV-associated lipodystrophy.

Tesamorelin has higher synthesis costs and is the most potent GHRH analog available with robust Phase III clinical trial data. Its pharmaceutical pedigree commands premium pricing.

PeptidesEuro is a research materials supplier operated by Pepticore LLC. We provide high-purity peptides and research compounds for in-vitro laboratory and scientific research purposes. All products are sold strictly for research use only and are not intended for human or animal consumption.

No. All products sold through meimx.com are intended strictly for in-vitro laboratory and scientific research purposes only. They are not intended for human or animal consumption, injection, ingestion, inhalation, or any form of administration to living organisms. By purchasing from PeptidesEuro, you acknowledge and agree to these terms as outlined in our Terms of Service.

No. Our products have not been evaluated, approved, or authorized by the U.S. Food and Drug Administration (FDA) or any other regulatory body. They are not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. PeptidesEuro is not a compounding pharmacy or outsourcing facility as defined under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act.

No. PeptidesEuro does not provide medical advice, treatment recommendations, or dosing instructions. Any information on our website, including product descriptions and referenced research, is provided for educational and informational purposes only. If you have medical questions, please consult a licensed healthcare provider.

Research Use Only means that our products are sold exclusively as reference standards and research materials for use in laboratory and scientific research settings. Purchasers agree to use all products solely for legitimate research purposes in compliance with all applicable laws and regulations.